Recorded Presentations from the NCCN 2014 Congress Series: NSCLC
Lung cancer is the leading cause of cancer death in the United States. Oncologists need to be aware of new treatment options and recommendations so they can implement the best treatment plans and thus improve outcomes for their patients with lung cancer. The 2014 NCCN Congress Series™: Utilizing Guidelines to Customize Patient Care in Non-Small Cell Lung Cancer discusses the most recent developments in diagnosis and treatment to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with non-small cell lung cancer.
These activities are designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with non-small cell lung cancer.
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are provided for all activities as well. Complete accreditation information is provided before each activity.
There is no fee for these educational activities.
Supported by educational grants from Astellas Scientific and Medical Affairs, Inc. and Genentech; Foundation Medicine, Inc.; Lilly; and Novartis Oncology. This program is supported by a grant from AstraZeneca. This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.